Tissue targeting and disease patterns in systemic vasculitis

Best Practice and Research: Clinical Rheumatology

Volumn 15, Issue 2, 2001, Pages 259-279

  Cid, Maria C ^a   Vilardell, Carme ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adhesion molecules; Chemokines; Disease phenotypes; Tissue targeting; Vasculitis

Indexed keywords

ANTIGEN; BETA1 INTEGRIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; LIGAND; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEMBRANE RECEPTOR; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; P SELECTIN GLYCOPROTEIN LIGAND 1; SCLEROPROTEIN; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE SEVERITY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MACROPHAGE; MECHANICAL STRESS; MICROORGANISM; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SYSTEMIC VASCULITIS; T LYMPHOCYTE; TARGET ORGAN; TISSUE DISTRIBUTION;

EID: 0034983213     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2001.0143     Document Type: Article

References (105)

1. The spectrum of vasculitis. Clinical, pathologic, immunologic and therapeutic considerations
2. Histopathologic specificity of systemic vasculitis
3. Systemic and isolated vasculitis: A rational approach to classification and pathologic diagnosis
4. Nomenclature of systemic vasculitides. Proposal of an international consensus conference
5. Wegener's granulomatosis
6. Vascular manifestations in giant-cell arteritis
7. Morphological changes in the large arteries in polymyalgia arteritica
8. Large artery involvement in giant-cell (temporal) arteritis
9. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis
10. The role of immune complexes and complement in tissue injury
11. Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa
12. Immunohistochemical characterization of inflammatory cells and immunological activation markers in muscle and nerve biopsies from patients with systemic vasculitis
13. An immunohistopathologic study in cutaneous necrotizing vasculitis
14. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes
15. The spectrum and treatment of virus-associated vasculitides
16. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients
17. A role for hepatitis C virus infection in type II cryoglobulinemia
18. Relation between infection and autoimmunity in mixed cryoglobulinemia
19. Vasculitis and infection with the human immunodeficiency virus
20. Polyarteritis nodosa in human immunodeficiency virus-infected patients
21. Cytomegalovirus vasculitis: Case reports and review of the literature
22. Murine γ-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: A new model for virus-induced vascular disease
23. Molecular mimicry and Lyme borreliosis: A shared antigenic determinant between Borrelia burgdorferi and human tissue
24. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside
25. Detection of Chlamydia pneumoniae in giant-cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells
26. The role of parvovirus B19 in the pathogenesis of giant-cell arteritis: A preliminary evaluation
27. Giant-cell arteritis. Characterization of candidate microbial sequences and evidence of immunologic relevance
28. Cytokines profiles in Wegener's granulomatosis. Predominance of type 1 (Th1) in the granulomatous inflammation
29. Immunodiagnostic and pathophysiologic aspects of anti-neutrophil cytoplasmic antibodies in vasculitis
30. Antineutrophil cytoplasmic antibodies
31. New developments in the pathogenesis of systemic vasculitis
32. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients
33. Elevated IL-4 and IL-13 production by T cell lines in Churg-Strauss syndrome
34. How do lymphocytes know where to go: Current concepts and enigmas of lymphocyte homing
35. Selection of successive tumour lines for metastasis
36. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines
37. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
38. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
39. Integrins: Versatility, modulation, and signaling in cell adhesion
40. Adhesion molecules. A rheumatologic perspective
41. CD31/PECAM-1 is a ligand for αvβ3 integrin involved in adhesion of leukocytes to endothelial cells
42. Requirement for CD44 in activated T cell extravasation into an inflammatory site
43. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1
44. Signaling through CD50 (ICAM-3) stimulates T lymphocyte binding to human umbilical vein endothelial cells and extracellular matrix proteins via an increase in β1 and β2 integrin function
45. Cellular polarization induced by chemokines: A mechanism for leukocyte recruitment?
46. Through and beyond the way: Late steps in leukocyte transendothelial migration
47. P-selectin/ICAM-I double mutant mice: Acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli
48. Selectins and neutrophil traffic: Margination and Streptococcus pneumoniae-induced emigration in murine lungs
49. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature
50. The alpha 4 integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo
51. Distinct roles of L-selectin and integrins α4β7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: The multistep model confirmed and refined
52. The cutaneous lymphocyte antigen is a skin homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule-1
53. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin
54. Adhesion molecules expressed on homing lymphocytes in model intestinal epithelial
55. T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs
56. Immunohistochemical study of endothelial cell adhesion molecules in cutaneous lesions of dermatomyositis
57. Leukocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idopathic inflammatory myopathies
58. Preferential expression of the mucosal homing receptor integrin α4β7 in gastrointestinal non-Hodgkin lymphomas
59. Cell adhesion receptors in lymphoma dissemination
60. Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis: An immunihistologic and clinical study in 42 patients
61. Endothelial cell activation and increased interleukin-1 secretion in the pathogenesis of acute Kawasaki disease
62. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classical polyarteritis nodosa
63. Cell adhesion molecules in the development of inflammatory infiltrates in giant-cell arteritis
64. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis
65. Intercellular adhesion molecule-1 deficiency protects MRL/Mpj-Fas (lpr) mice from early lethality
66. The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetric GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat
67. Anti-adhesion therapy as an interventional strategy for autoimmune inflammation
68. Chemokines. Chemotactic cytokines that mediate inflammation
69. T-cell function and migration
70. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing
71. Chemokines and cell migration in secondary lymphoid organs
72. Chemokine receptors in lymphoid organ homeostasis
73. CCR7 coordinates the primary immune responses by establishing functional microenvironments in secondary lymphoid organs
74. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
75. Flexible programs of chemokine receptor expression of human polarized T helper 1 and 2 lymphocytes
76. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
77. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
78. Upregulation of integrin α6/βI and chemokine receptor CCRI by interleukin-12 promotes the migration of human type I helper T cells
79. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7
80. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes
81. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules
82. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
83. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells
84. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lympocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis
85. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
86. Eotaxin: From an eosinophilic chemokine to a major regulator of allergic reactions
87. Liver metastasis formation by laminin-I peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells
88. Laminin-α1-chain sequence Leu-Gln-Val-Gln-Leu-Ser-lle-Arg (LQVQLSIR) enhances murine melanoma cell metastases
89. Osteonectin promotes prostate cancer cell migration and invasion. A possible mechanism for metastasis to bone
90. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome
91. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant-cell (temporal) arteritis
92. Inflammation-induced angiogenic response and the development of cranial ischemic complications in giant-cell arteritis
93. Interferon-α may exacerbate cryoglobulinemia-related ischemic manifestations. An adverse effect potentially related to its anti-angiogenic activity
94. The initial systemic inflammatory response may predict the duration of corticosteroid treatment in patients with giant-cell arteritis (GCA)
95. IL-6 and TNFα serum concentrations correlate with the intensity of systemic inflammatory response in patients with giant-cell arteritis
96. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant-cell arteritis
97. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant-cell arteritis
98. Unlinking tumor necrosis factor biology from the Major Histocompatibility Complex: Lessons from human genetics and animal models
99. TNFα gene polymorphism: Clinical and biological implications
100. HLA-DR4 in giant-cell arteritis: Association with polymyalgia rheumatica syndrome
101. Polymyalgia rheumatica: A syndrome associated with the HLA-DR4 antigen
102. The HLA-DRBI locus as a genetic component in giant cell arteritis: Mapping of a disease-linked sequence motif to the antigen binding site of the HAL-DR molecule
103. Disease pattern in cranial and large-vessel giant-cell arteritis
104. Complexes between proteinase 3, αl-antitrypsin and proteinase 3 anti-neutrophil cytoplasmic antibodies: A comparison between αl antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis
105. Analysis of Fc gammaRII gene plymorphisms in Wegener's granulomatosis